Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Shineco Inc (SISI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/18/2025: SISI (3-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Analysis of Past Performance
Type Stock | Historic Profit 1570.89% | Avg. Invested days 114 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  5.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 06/18/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 7.03M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 2599618 | Beta -0.77 | 52 Weeks Range 0.30 - 117.65 | Updated Date 06/19/2025 |
52 Weeks Range 0.30 - 117.65 | Updated Date 06/19/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 833.18 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -9178.81% |
Management Effectiveness
Return on Assets (TTM) -10.33% | Return on Equity (TTM) -82.95% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 18641482 | Price to Sales(TTM) 0.73 |
Enterprise Value 18641482 | Price to Sales(TTM) 0.73 | ||
Enterprise Value to Revenue 1.94 | Enterprise Value to EBITDA -3.23 | Shares Outstanding 20745800 | Shares Floating 15546522 |
Shares Outstanding 20745800 | Shares Floating 15546522 | ||
Percent Insiders 25 | Percent Institutions 0.5 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Shineco Inc
Company Overview
History and Background
Shineco, Inc. was founded in 1997 in China. It has evolved from a provider of specialized textiles to a healthcare and consumer product company focusing on traditional Chinese medicine (TCM). They primarily sell and distribute these products. Public trading started in the US Markets in 2010.
Core Business Areas
- Traditional Chinese Medicine (TCM) Products: Production, sales, and distribution of TCM products, including herbal medicines, dietary supplements, and healthcare products.
- Textile Products: Manufacturing and sale of specialized textile products, although this is a smaller part of their current business.
Leadership and Structure
Information on Shineco's specific leadership team and organizational structure is not readily available in common financial sources. SEC filings or direct company resources would be needed for a detailed outline.
Top Products and Market Share
Key Offerings
- Traditional Chinese Medicine Products: Shineco focuses on producing and distributing various TCM products. Market share data is difficult to obtain specifically for Shineco in the broad TCM market. Competitors include large pharmaceutical and TCM companies within China.
- Dietary Supplements and Healthcare Products: Alongside TCM, Shineco offers various dietary supplements and healthcare products. Market share data for this specific segment is challenging to ascertain. Competitors are other supplement and healthcare product manufacturers.
Market Dynamics
Industry Overview
The TCM industry is growing globally, driven by increased interest in natural and alternative medicine. The demand is especially large in Asian markets. Government regulation and quality control are important factors.
Positioning
Shineco is positioned as a player in the TCM and healthcare product market, with a focus on production and distribution. Competitive advantages likely lie in the quality and pricing of their products and their distribution networks.
Total Addressable Market (TAM)
The global TCM market is estimated to be in the billions of dollars. Shineco's positioning relates to its ability to capture a portion of this TAM through its product offerings and geographic reach.
Upturn SWOT Analysis
Strengths
- Established presence in the TCM market
- Product diversification in healthcare products
- Distribution network in key markets
- Experienced management team in China
Weaknesses
- Limited financial resources compared to larger competitors
- Dependence on the Chinese market
- Brand recognition is limited on a global level
- Lack of SEC filings to provide further clarity of business performance
Opportunities
- Expanding into new geographic markets
- Developing innovative TCM products
- Partnerships with healthcare providers
- Capitalizing on increased consumer interest in natural medicine
Threats
- Intense competition from established players
- Changes in government regulations
- Fluctuations in raw material prices
- Risk of counterfeiting and intellectual property infringement
Competitors and Market Share
Key Competitors
- CRNJ
- HEPA
- HLTH
Competitive Landscape
Shineco faces significant competition in the TCM and healthcare market. Its advantages depend on product quality, pricing, and distribution efficiency, and it must compete against established players with more significant resources. Its market capitalization is significantly below competitors such as CRNJ.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends are difficult to assess accurately without access to comprehensive financial data.
Future Projections: Future growth projections are not readily available from analyst estimates.
Recent Initiatives: Recent initiatives are difficult to determine without detailed financial disclosures and press releases.
Summary
Shineco Inc is a company that operates within the TCM and healthcare product market. Due to the lack of SEC filings, the true financial health of the company is unknown. While it has a presence in a growing market, accessing detailed financial data and growth prospects is difficult. Its ability to compete effectively depends on navigating regulatory challenges and innovation within TCM.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company press releases
- Third-party market research reports
- Google Finance
- SEC Filings (where available)
- YCHARTS
Disclaimers:
The information provided is for informational purposes only and does not constitute financial advice. Investment decisions should be based on individual due diligence and consultation with a financial professional. Financial data may be outdated due to limited SEC filings.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Shineco Inc
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2016-09-28 | CEO & Executive Director Ms. Jennifer Zhan | ||
Sector Consumer Defensive | Industry Farm Products | Full time employees 119 | Website https://www.biosisi.com |
Full time employees 119 | Website https://www.biosisi.com | ||
Shineco, Inc., through its subsidiaries, plants, processes, and distributes agricultural produce. The company also engages in the development, production, and distribution of diagnostic products and related medical devices; trading of fresh fruits; and processing, producing, and distribution of silk and silk fabrics, as well as other by-products. In addition, it operates a restaurant in Fuzhou. The company was formerly known as Beijing Tenet Jove Technological Development Co., Ltd. Shineco, Inc. was incorporated in 1997 and is based in Beijing, the People's Republic of China.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.